Burrage Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-294,620
| Closed | -$5.55M | – | 4 |
|
|
2021
Q2 | $5.55M | Buy |
294,620
+22,227
| +8% | +$419K | 5.57% | 7 |
|
|
2021
Q1 | $4.16M | Buy |
272,393
+48,264
| +22% | +$737K | 3.37% | 12 |
|
|
2020
Q4 | $3.16M | Sell |
224,129
-17,149
| -7% | -$242K | 2.41% | 19 |
|
|
2020
Q3 | $3.78M | Buy |
241,278
+4,884
| +2% | +$76.5K | 2.98% | 15 |
|
|
2020
Q2 | $4.14M | Sell |
236,394
-45,878
| -16% | -$804K | 2.9% | 19 |
|
|
2020
Q1 | $4.02M | Buy |
282,272
+76,546
| +37% | +$1.09M | 3.96% | 9 |
|
|
2019
Q4 | $5.16M | Buy |
+205,726
| New | +$5.16M | 3.46% | 12 |
|